NEW: A new analysis concludes that Qatar has spent over $400 billion in nearly every corner of the U.S., from the defense industry to disaster relief.
https://t.co/g7097leQAi
Let’s be honest — and I say this recognizing there are some excellent reporters at the NYT.
But as an institution, the NYT has devoted enormous energy to eroding the legitimacy of Israel as a Jewish state. Its coverage too often fuels a global campaign of political, economic, and moral warfare designed to isolate Israel, strip it of American support and make it unable to defend itself.
What began as reasonable criticisms of Israeli policy has, in many cases, become something far more corrosive: an unrelenting effort to recast the Jewish state itself as uniquely evil and illegitimate.
the rare disease coalition's full survey results are posted. the patient advocacy leaders who responded clearly think the bar fda is setting for rare disease is too high, and that beneficial medicines are being delayed. we should listen to them. and to those who discount the opinions of folks impacted by disease, saying they can't be objective, or are not informed etc, i would point out that at fda adcoms patient advocates do not vote for approval more often than expert physicians. these are people who have been thrust into becoming experts for their loved ones, a job they didn't ask for, and who the numbers say balance risk benefit similarly to physicians.
https://t.co/1x1sWxtllm
Sen. John Fetterman: "This was one of the most evil people that ever lived. [Khamenei] And after 37 years in Iran, he's been eliminated, you know, and I can't imagine why Democrat, Republican, everyone can't celebrate that.”
@matthewherper FDA needs to look hard at these data, appreciate the devastating consequences of this disease, and understand there’s nothing to be done. The lack of a clear pathway here will continue the generational devastation and economic turbulence for those suffering from Huntington’s
Every member in the U.S. Senate agrees we cannot allow Iran to acquire a nuclear weapon.
I’m baffled why so many are unwilling to support the only action to achieve that.
Empty sloganeering vs. commitment to global security — which is it?
BREAKING: Senator Fetterman with some much needed clarity.
“You can put out tweets and statements to support peace, but to actually create real peace, you have to do these kinds of actions and that’s why I support this.”
I am beyond heartbroken about the news that we have lost a cherished former @Alnylam colleague, Leena Dalal.
Leena would always fill a room with smiles and happiness.
R.I.P., Leena.
Proud to be named one of America's Most Responsible Companies by Newsweek for the 4th year running! This recognition reflects our commitment to our communities and responsible corporate citizenship.
Learn more: https://t.co/k1JU4wHoUl
#CSR#ESG#Sustainability#Newsweek
🫶🏽They’re home🫶🏽
After endless days in darkness, they’re finally free.
The Nova Music Festival was a symbol of peace and freedom - a desert rave where young people came to dance at sunrise.
On October 7, 2023, Hamas terrorists attacked the festival, massacring over 370 people, committing horrific sexual violence and abducting dozens into Gaza.
Today, the 20 hostages who survived 738 days of torture are finally home.
The road to healing begins now.
Welcome 🇮🇱home. We’ve waited for you too long.
Since the horrific terrorist attack on Israel last year, Natalie & I have channeled our grief into action by offering a healing hand through donations to @AFMDA. Join us in helping: https://t.co/CRzZoQOeOF #mdasaveslives
I'm devastated for the six innocent Israeli hostages held captive for nearly a year and murdered by Hamas. My thoughts are with their loved ones as they mourn unimaginable loss. Today I’ll hold my family close as we hope for the safe return of all held captive. #Bringthemhomenow
I commend @AmericanHeartMA's incredible work to enhance emergency responses in Boston. Comprehensive resources and tools like these significantly improve response capabilities in our communities. Together, we can support better #hearthealth. More: https://t.co/YoJXCGBX6N
Congratulations to the @Alnylam team - 20 years! Grit, perseverance, and dedication to advancing science are the fuel for innovation. Patients are waiting!
We are pleased to share positive topline results from our HELIOS-B Phase 3 study of vutrisiran, an investigational #RNAi therapeutic in development for the treatment of #ATTR#amyloidosis w/ cardiomyopathy. Read the press release: https://t.co/LnxVwYjj6n #RNAiTherapeutics#siRNA